| value |
{"aggregator_url":"https://www.nasdaq. {"aggregator_url":"https://www.nasdaq.com/articles/monday-4-6-insider-buying-report-anvs-vale","as_of":"2026-04-06T17:13:11.811157+00:00","canonical_url":"https://www.nasdaq.com/articles/monday-4-6-insider-buying-report-anvs-vale","enrichment":{"aggregator_url":"https://www.nasdaq.com/articles/monday-4-6-insider-buying-report-anvs-vale","article_chars":2483,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_1d0232a6a5617fd7","canonical_host":"nasdaq.com","canonical_is_aggregator":false,"canonical_url":"https://www.nasdaq.com/articles/monday-4-6-insider-buying-report-anvs-vale","content_type":"text/html; charset=utf-8","enriched_at":"2026-04-06T22:30:58.988352+00:00","extraction_method":"heuristic","fetched_description":"As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys.At Annovis Bio, a filing with the SEC revealed that on Thursday, Director Michael B","fetched_title":"Monday 4/6 Insider Buying Report: ANVS, VALE | Nasdaq","final_url":"https://www.nasdaq.com/articles/monday-4-6-insider-buying-report-anvs-vale","html_truncated":false,"paywall_likely":false,"publisher_domain":"nasdaq.com","publisher_resolution":"canonical_url","requested_url":"https://www.nasdaq.com/articles/monday-4-6-insider-buying-report-anvs-vale","source_event_id":"evt_ffcbe046e54a","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"fp":"dcc9e99c5ab76087","kind":"unusual_volume","published_at":"2026-04-06T16:37:58+00:00","publisher_domain":"nasdaq.com","signal_understanding":{"analysis_basis":"article","claim_confidence":0.9,"dates_mentioned":["2026-04-06"],"entities":[{"asset_class":"equity","name":"Annovis Bio","relevance":"high","symbol":"ANVS","type":"company"},{"asset_class":"equity","name":"Vale","relevance":"high","symbol":"VALE","type":"company"}],"event_type":"other","information_gaps":["No specific volume ratio vs average provided for ANVS or VALE.","No confirmation of news related to the insider buying beyond the reported transactions."],"key_facts":["Hoffman is up about 31.9% on ANVS based on today's trading high of $2.77.","ANVS is trading up about 18.8% on the day.","Arap is up about 1.2% on VALE based on today's trading high of $16.30.","VALE is trading up about 0.1% on the day."],"numeric_claims":[{"label":"Hoffman's purchase amount","value":"713,800 shares"},{"label":"Hoffman's purchase price","value":"$2.10"},{"label":"Arap's purchase amount","value":"12,990 shares"},{"label":"Arap's purchase price","value":"$16.11"}],"primary_claim":"Director Michael B. Hoffman of Annovis Bio bought 713,800 shares at $2.10 each, totaling $1.5M, while Executive VP Sobrinho Sami Arap of Vale bought 12,990 shares at $16.11 each, totaling $209,290.","relevance_score":0.8,"sentiment":"positive","source_quality":"high","summary":"Recent insider buying activity was reported for Annovis Bio (ANVS) and Vale (VALE), with significant purchases indicating potential positive sentiment from insiders.","topics":["insider buying","stock performance","market trends"]},"source":"Nasdaq Markets","source_domain":"nasdaq.com","summary":"As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys. At Annovis Bio, a filing with the SEC revealed that on Thursday, Director Michael B","tickers":[],"title":"Monday 4/6 Insider Buying Report: ANVS, VALE","url":"https://www.nasdaq.com/articles/monday-4-6-insider-buying-report-anvs-vale"}... |